(S)-2-{4-[2-(2-Hydroxy-3-phenoxy-propylamino)-ethoxy]-phenoxy}-N-(2-methoxy-ethyl)-acetamide

ID: ALA1788312

Cas Number: 129689-30-1

PubChem CID: 121877

Product Number: Z340504, Order Now?

Max Phase: Preclinical

Molecular Formula: C22H30N2O6

Molecular Weight: 418.49

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCNC(=O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1

Standard InChI:  InChI=1S/C22H30N2O6/c1-27-13-12-24-22(26)17-30-21-9-7-20(8-10-21)28-14-11-23-15-18(25)16-29-19-5-3-2-4-6-19/h2-10,18,23,25H,11-17H2,1H3,(H,24,26)/t18-/m0/s1

Standard InChI Key:  RVMBDLSFFNKKLG-SFHVURJKSA-N

Molfile:  

     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
   11.9650   -3.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3768   -4.1924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3768   -2.7682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7238   -2.7625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5280   -2.7968    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1356   -3.4831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8889   -2.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9521   -2.7854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2531   -2.7511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2429   -3.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3877   -2.7682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8074   -3.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4771   -3.4717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4771   -2.0476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6535   -3.4717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6535   -2.0476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9464   -1.9618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5382   -3.1629    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4358   -3.4831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6728   -3.1914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2004   -2.7682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1083   -3.1743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8176   -2.7511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6122   -3.4831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0867   -2.8025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8074   -4.0493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8476   -4.1924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0867   -4.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3775   -3.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3775   -4.0493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  6  1  0
  5 10  1  0
  6  1  1  0
  7  4  1  0
  8 20  1  0
  9 16  1  0
 10  8  1  0
 11 22  1  0
 12  5  1  0
 13  7  2  0
 14  7  1  0
 15 13  1  0
 16 14  2  0
  8 17  1  1
 18  9  1  0
 19 24  1  0
 20 11  1  0
 21  3  1  0
 22 23  1  0
 23 18  1  0
 24 21  1  0
 25 12  2  0
 26 12  1  0
 27 19  1  0
 28 26  2  0
 29 25  1  0
 30 28  1  0
  9 15  2  0
 30 29  2  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adrb3 Beta-3 adrenergic receptor (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 418.49Molecular Weight (Monoisotopic): 418.2104AlogP: 1.24#Rotatable Bonds: 15
Polar Surface Area: 98.28Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.99CX Basic pKa: 8.79CX LogP: 1.15CX LogD: -0.24
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.37Np Likeness Score: -1.00

References

1. Howe R, Rao BS, Holloway BR, Stribling D..  (1992)  Selective beta 3-adrenergic agonists of brown adipose tissue and thermogenesis. 2. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetamides.,  35  (10): [PMID:1350310] [10.1021/jm00088a010]
2. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]
3. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]
4. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]
5. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius.  (2021)  HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators,  [10.6019/CHEMBL4808148]